Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Mahsheena K M

Mahsheena K M

Aster MIMS hospital, India.

Title: The validity of immunocytochemistry in differentiating between benign and malignant thyroid neoplasms pre-operatively

Biography

Biography: Mahsheena K M

Abstract

FNAC is the most commonly used diagnostic modality for the pre-operative assessment of thyroid neoplasms.. However, FNAC when used alone has its own pitfalls including inability to differentiate benign and malignant follicular neoplasms, difficulty in identifying follicular variant of papillary carcinoma etc. This study addresses the issue of whether preferential overexpression of galectin-3 in thyroid malignancies can serve to make a presurgical diagnosis between benign and malignant thyroid neoplasms on FNAC. The other marker used was TTF-1,to identify the thyroid origin of the neoplastic cells.

OBJECTIVE: To estimate the sensitivity, specificity and predictive values of galectin-3 and TTF-1 in detecting malignant neoplasms of the thyroid on FNA smears.

STUDY SAMPLE: FNA smears of solitary thyroid nodules taken at the Cytopathology division in the Department of Pathology, Aster MIMS hospital Calicut  a tertiary health care system were analysed from June 2016 to July 2017.

STUDY METHOD: Immunocytochemistry was performed with galectin-3 and TTF-1 on fresh FNA smears by the standard protocol. Positive staining for galectin-3 was considered when any single epithelial cell showed cytoplasmic or nucleo-cytoplasmic immunostaining. Positive staining for TTF-1 was considered when any single epithelial cell showed nuclear immunostaining. Postoperative histological diagnosis represented the gold-standard.

RESULTS:Out of the total 39 cases Gal-3 positivity was seen in 100% (16/16) cases of malignancy and 9% (2/22) cases of benign thyroid lesions.Also, although not statistically significant, the 2 cases of follicular adenoma in our study group were negative whereas grade-2 positivity was seen in the case of follicular carcinoma, minimally invasive type.

CONCLUSION:Galectin-3 expression is thus a reliable marker of malignancy (particularly in papillary carcinoma) and strong Gal-3 expression should therefore prompt immediate surgical removal. Immunostaining should be assessed along with Pap stained smears. This study further demonstrates efficacy when smears themselves were used instead of cell block sections.